1h Free Analyst Time
The intrauterine contraceptive devices (IUD) market is poised to grow by $965.49 million during 2023-2027, accelerating at a CAGR of 3.98% during the forecast period. The market is driven by the increasing rate of unintended pregnancies and unwanted abortions, initiatives by government and non-profit organizations, and the high growth of e-commerce platforms.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the intrauterine contraceptive devices (IUD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The intrauterine contraceptive devices (IUD) market is segmented as below:
By Type
- Hormonal intrauterine device
- Copper intrauterine device
By End-user
- Hospitals
- Gynecology clinics
- Others
By Geography
- North America
- Europe
- APAC
- Rest of World (ROW)
This report on the intrauterine contraceptive devices (IUD) market covers the following areas:
- Intrauterine contraceptive devices (IUD) market sizing
- Intrauterine contraceptive devices (IUD) market forecast
- Intrauterine contraceptive devices (IUD) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Drivers, Challenges, and Trends1.1 Market drivers
1.1.1 Technological innovations in COB LEDs
1.1.2 Growing adoption of COB LEDs in smart lighting
1.1.3 Growing demand from the automotive sector
1.2 Market challenges
1.2.1 Development of CSP LEDs
1.2.2 Emergence of quantum boards
1.2.3 High import duties
1.3 Impact of drivers and challenges
1.4 Market trends
1.4.1 Adoption of COB LEDs in horticulture
1.4.2 Development of high-color rendering index (CRI) COB LEDs
1.4.3 Growing interest in human-centric lighting
01: Impact of drivers and challenges
Executive Summary
The analyst recognizes the following companies as the key players in the global intrauterine contraceptive devices (IUD) market: AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc..Commenting on the report, one of the report's analysts said: 'The latest trend gaining momentum in the market is long-term efficacy and increased acceptance.'
According to the report, one of the major drivers for this market is the increasing rate of unintended pregnancies and unwanted abortions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Bayer AG
- DKT International
- Durbin PLC
- EurimPharm Arzneimittel GmbH
- EUROGINE SL
- Gima Spa
- HLL Lifecare Ltd.
- Krishco Medical Products Pvt. Ltd.
- Laboratoire HRA Pharma SAS
- Melbea Innovations Ltd.
- Meril Life Sciences Pvt. Ltd.
- Ocon Medical Ltd.
- Pregna International Ltd
- Prosan International BV
- SMB Corp. of India
- TESPRO LLC
- The Cooper Companies Inc.
- TRIMEDIC SUPPLY NETWORK Ltd.
- Viatris Inc.